Survival analysis indicated that highly CD248 expression accompanied a bad prognosis (P < 0.05, Figure 5A), while the expression level of PSMA did not significantly affect the overall survival of patients with BLCA (P > 0.05, Figure 5B). The gene discussed is FOLH1; the disease is bladder transitional cell carcinoma.